Wisconsin is tapping money extracted from the pharmaceutical companies that fueled the opioid epidemic to pay for something health insurance almost never covers: the cost of a bed and meals while someone gets clean.
The Wisconsin Department of Health Services has posted a solicitation seeking residential treatment providers to receive funding specifically for room and board costs, a chronic gap in the treatment system that has kept residential rehab out of reach for uninsured and low-income patients across the state.
The gap has a specific cause. A 1965 federal rule known as the IMD exclusion bars Medicaid from paying for care in residential facilities with more than 16 beds. That means Medicaid can cover the clinical side of residential treatment, therapy, medication and medical oversight, but not the cost of housing patients while they receive it. For facilities to stay financially viable, those room-and-board costs have to come from somewhere. For many patients, they never do.
In Wisconsin, that problem is compounded by the state's decision not to expand Medicaid under the Affordable Care Act. Wisconsin is one of only 10 states that has not done so, meaning a larger portion of low-income residents with addiction have no coverage at all, making settlement-funded room and board even more critical here than in states with broader Medicaid rolls.
The funding comes from Wisconsin's share of the national opioid litigation settlements, a series of agreements reached between state attorneys general and major pharmaceutical manufacturers, distributors and pharmacy chains beginning in 2022. Wisconsin is set to receive approximately $780 million over 18 years, with 30% flowing through the state and administered largely by DHS. This solicitation represents one of the later tranches of those dollars being deployed for treatment infrastructure.
The need is substantial. Wisconsin recorded 1,827 overdose deaths in 2022, the highest on record for the state. While that number has edged down since, demand for residential treatment continues to outpace supply, particularly in rural northern counties and on tribal lands where treatment facilities are few and far between. Milwaukee County carries an outsized share of the burden, with Black residents dying from overdoses at rates far higher than white residents.
DHS has used earlier rounds of settlement funding for tribal treatment services, mobile methadone units and naloxone distribution. The specific bed count, dollar amounts and geographic targeting for this room-and-board program were not immediately specified in publicly available materials and would need to be confirmed through the solicitation directly.
The application process is now open for residential treatment providers interested in receiving the funding.
